Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +335.75%
#4 aPriori aPriori +131.95%
#5 Bedrock Bedrock +76.08%
#6 Cysic Cysic +50.91%
#7 Prom Prom +45.70%
#8 Playnance Playnance +35.00%
#9 Bitway Bitway +27.78%
#10 COTI COTI +27.04%
Coin of the day
Wrapped One Wrapped One
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Cotinga Pharmaceuticals Inc. Cotinga Pharmaceuticals Inc.

Cotinga Pharmaceuticals Inc.

COTQF
Clasificación en acciones #42319
Cotinga Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm focused... Cotinga Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm focused on developing innovative treatments for cancer and other medical conditions currently lacking adequate solutions. Its leading therapeutic asset is COTI-2, an oral small molecule formulated to target the p53 tumor suppressor gene. The company is also progressing COTI-219, another oral small molecule compound, specifically engineered to inhibit mutant forms of KRAS without affecting the normal functions of the KRAS gene. In collaboration with St. Vincent's University Hospital, Cotinga is conducting research to evaluate COTI-2 when combined with eribulin for patients suffering from triple-negative metastatic breast cancer. The company, which was previously known as Critical Outcome Technologies Inc., rebranded to Cotinga Pharmaceuticals Inc. in January 2018. Its corporate base is situated in Toronto, Canada.
Precio por acción
$0.0001
Última sincronización: 2026-07-02
Capitalización bursátil
$2.20K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
CA
Comercio Cotinga Pharmaceuticals Inc. (COTQF)

Categoría

Healthcare
Historial del precio de la acción de Cotinga Pharmaceuticals Inc. (COTQF)
Precio más alto de cierre: $0.00 el 2026-07-01

Precio más bajo de cierre: $0.42 el 2009-09-01
Historial del precio de la acción de Cotinga Pharmaceuticals Inc. desde 2009 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 0.00%
2025 0.00%
2024 0.00%
2023 0.00%
2022 900.00%
2021 -99.99%
2020 3,089.48%
2019 12.40%
2018 -95.52%
2017 -73.25%
2016 53.81%
2015 3.50%
2014 33.09%
2013 16.94%
2012 -61.29%
2011 145.58%
2010 -65.69%
2009 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 36.13%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 37.02%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.38 8.73%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $263.09 20.45%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -5.56%
KR